Ventus Therapeutics

Ventus Therapeutics

Edit info

  • Founded: 2019
  • Location: Waltham, MA
  • Employee range: 11 - 50
  • Clinical stage: Clin0
  • Therapy area: Immunology, Rheumatology
  • Drug types: IMM, RHU, DRM, NEU, GI, HEP, NPH, CVV
  • Lead product: VENT-03
  • Funding: $140M C Feb 2022; $100M Apr 2021; $60M A May 2020
  • Investors: Versant Ventures


ventustx.com

linkedin.com

job board


Drug notes:

VENT-02 Clin1 neuro; VENT-01 Clin0 renal, cardiovascular, hepatic; VENT-05 RD undisclosed; VENT-04 RD various

About:

Ventus Therapeutics uses structural biology and computational chemistry tools to address a wide range of diseases, including immunology, inflammatory, and neurological disorders. Their drug discovery platform models all protein conformations to identify druggable pockets in order to create a “blueprint” for developing small molecule therapeutics. Through their platform, Ventus can virtually screen libraries of compounds to identify molecules that resemble the “blueprint”and then optimize them for improved efficacy. They aim to address current limitations in industry. Their expertise in protein engineering, structure determination, and expression enables them to confront previously challenging targets like the inflammasome and nucleic acid sensing pathways.

Jobs:

Ventus Therapeutics
Senior Manager, IT
Waltham, MA|21 days ago
Apply
Ventus Therapeutics
Human Resources Intern/Co-op (Spring 2025)
Waltham, MA|Not provided


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com